229 related articles for article (PubMed ID: 33864520)
1. Interactions in cancer treatment considering cancer therapy, concomitant medications, food, herbal medicine and other supplements.
Wolf CPJG; Rachow T; Ernst T; Hochhaus A; Zomorodbakhsch B; Foller S; Rengsberger M; Hartmann M; Hübner J
J Cancer Res Clin Oncol; 2022 Feb; 148(2):461-473. PubMed ID: 33864520
[TBL] [Abstract][Full Text] [Related]
2. Complementary and alternative medicine (CAM) supplements in cancer outpatients: analyses of usage and of interaction risks with cancer treatment.
Wolf CPJG; Rachow T; Ernst T; Hochhaus A; Zomorodbakhsch B; Foller S; Rengsberger M; Hartmann M; Huebner J
J Cancer Res Clin Oncol; 2022 May; 148(5):1123-1135. PubMed ID: 34228225
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of polypharmacy, polyherbacy, nutritional supplement use and potential product interactions among older adults living on the United States-Mexico border: a descriptive, questionnaire-based study.
Loya AM; González-Stuart A; Rivera JO
Drugs Aging; 2009; 26(5):423-36. PubMed ID: 19552494
[TBL] [Abstract][Full Text] [Related]
4. Are physicians aware of the risks of alternative medicine?
Silverstein DD; Spiegel AD
J Community Health; 2001 Jun; 26(3):159-74. PubMed ID: 11478563
[TBL] [Abstract][Full Text] [Related]
5. Potential interactions of complementary and alternative medicine with cancer therapy in outpatients with gynecological cancer in a comprehensive cancer center.
Zeller T; Muenstedt K; Stoll C; Schweder J; Senf B; Ruckhaeberle E; Becker S; Serve H; Huebner J
J Cancer Res Clin Oncol; 2013 Mar; 139(3):357-65. PubMed ID: 23099993
[TBL] [Abstract][Full Text] [Related]
6. Complementary and alternative medications consumed by renal patients in southern Germany.
Nowack R; Ballé C; Birnkammer F; Koch W; Sessler R; Birck R
J Ren Nutr; 2009 May; 19(3):211-9. PubMed ID: 19251442
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of potential interactions of medications, including herbs and supplements, before, during, and after chemotherapy in patients with breast and prostate cancer.
Lee RT; Kwon N; Wu J; To C; To S; Szmulewitz R; Tchekmedyian R; Holmes HM; Olopade OI; Stadler WM; Von Roenn J
Cancer; 2021 Jun; 127(11):1827-1835. PubMed ID: 33524183
[TBL] [Abstract][Full Text] [Related]
8. Complementary and alternative medicine use among cancer patients in Palestine with special reference to safety-related concerns.
Ali-Shtayeh MS; Jamous RM; Salameh NM; Jamous RM; Hamadeh AM
J Ethnopharmacol; 2016 Jul; 187():104-22. PubMed ID: 27125594
[TBL] [Abstract][Full Text] [Related]
9. Risk of interactions between complementary and alternative medicine and medication for comorbidities in patients with melanoma.
Loquai C; Dechent D; Garzarolli M; Kaatz M; Kaehler KC; Kurschat P; Meiss F; Stein A; Nashan D; Micke O; Muecke R; Muenstedt K; Stoll C; Schmidtmann I; Huebner J
Med Oncol; 2016 May; 33(5):52. PubMed ID: 27090799
[TBL] [Abstract][Full Text] [Related]
10. Biopharmacologic and herbal therapies for cancer: research update from NCCAM.
Richardson MA
J Nutr; 2001 Nov; 131(11 Suppl):3037S-40S. PubMed ID: 11694644
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of drug-herb and drug-supplement interactions in older adults: a cross-sectional survey.
Agbabiaka TB; Spencer NH; Khanom S; Goodman C
Br J Gen Pract; 2018 Oct; 68(675):e711-e717. PubMed ID: 30249608
[TBL] [Abstract][Full Text] [Related]
12. Adverse events associated with complementary and alternative medicine use in ovarian cancer patients.
Sweet ES; Standish LJ; Goff BA; Andersen MR
Integr Cancer Ther; 2013 Nov; 12(6):508-16. PubMed ID: 23625025
[TBL] [Abstract][Full Text] [Related]
13. A pilot study to assess students' perceptions, familiarity, and knowledge in the use of complementary and alternative herbal supplements in health promotion.
Zimmerman C; Kandiah J
Altern Ther Health Med; 2012; 18(5):28-33. PubMed ID: 22894888
[TBL] [Abstract][Full Text] [Related]
14. Concomitant therapy in people with epilepsy: potential drug-drug interactions and patient awareness.
Eyal S; Rasaby S; Ekstein D
Epilepsy Behav; 2014 Feb; 31():369-76. PubMed ID: 24211058
[TBL] [Abstract][Full Text] [Related]
15. The use of complementary and alternative medicine by patients in routine care and the risk of interactions.
Firkins R; Eisfeld H; Keinki C; Buentzel J; Hochhaus A; Schmidt T; Huebner J
J Cancer Res Clin Oncol; 2018 Mar; 144(3):551-557. PubMed ID: 29356888
[TBL] [Abstract][Full Text] [Related]
16. [Norwegian cancer patients and the health food market--what is used and why?].
Johansen R; Toverud EL
Tidsskr Nor Laegeforen; 2006 Mar; 126(6):773-5. PubMed ID: 16541172
[TBL] [Abstract][Full Text] [Related]
17. Cancer patients at risk of herb/food supplement-drug interactions: a systematic review.
Alsanad SM; Williamson EM; Howard RL
Phytother Res; 2014 Dec; 28(12):1749-55. PubMed ID: 25158128
[TBL] [Abstract][Full Text] [Related]
18. Herbal supplements: are they worth the risk?
Johns Hopkins Med Lett Health After 50; 2013; 24(6):5. PubMed ID: 24000430
[No Abstract] [Full Text] [Related]
19. Herbal medication: potential for adverse interactions with analgesic drugs.
Abebe W
J Clin Pharm Ther; 2002 Dec; 27(6):391-401. PubMed ID: 12472978
[TBL] [Abstract][Full Text] [Related]
20. Herbal medications and other dietary supplements. A clinical review for physicians caring for older people.
Pitkälä KH; Suominen MH; Bell JS; Strandberg TE
Ann Med; 2016 Dec; 48(8):586-602. PubMed ID: 27427263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
